What is the risk of pregnancy for a 31‑year‑old woman with a Fontan circulation after repair of hypoplastic left heart syndrome, and what contraceptive options are recommended?

Pregnancy Risk in Fontan Circulation

Pregnancy after Fontan repair for hypoplastic left heart syndrome carries substantial maternal and fetal risks, with miscarriage rates of 50-53%, preterm delivery rates of 40-57%, and maternal cardiac complications in up to 29% of cases, but is feasible in carefully selected patients with close multidisciplinary monitoring 1, 2, 3.

Maternal Risks

The 31-year-old woman faces several critical maternal risks:

• Cardiac complications occur in approximately 7-29% of pregnancies, primarily supraventricular arrhythmias (pooled incidence 6.59%) and heart failure (pooled incidence 3.71%) 1, 2
• Thrombotic events remain a concern given the unique Fontan hemodynamics with chronically elevated central venous pressure and nonpulsatile pulmonary blood flow 4
• Maternal mortality is rare in recent series, with no deaths reported in the most recent meta-analysis of 400 pregnant women with Fontan circulation 2
• Long-term prognosis: Nearly one-third of Fontan patients will die or require transplant within 35 years post-Fontan, though whether pregnancy accelerates this decline remains unclear 4, 5

Fetal and Neonatal Risks

The fetal risks are substantial and include:

• Miscarriage rate: 50-53% across multiple studies 1, 3
• Preterm delivery: 40-57% of live births occur prematurely (mean gestational age 33-36 weeks) 2, 3
• Low birth weight: Mean birth weight approximately 2,086-2,344 grams 3, 6
• Neonatal mortality: 4.38% pooled incidence, primarily from prematurity complications 2
• Congenital heart disease in offspring: Small risk (approximately 7% in one series) 3

Contraceptive Recommendations

For this patient, long-acting reversible contraception (LARC) methods are strongly preferred, specifically the levonorgestrel intrauterine device (IUD) or progestin-only implants, avoiding estrogen-containing contraceptives due to thrombotic risk.

The contraception landscape in Fontan patients reveals concerning patterns:

• 44% of Fontan patients use no contraception, representing a critical gap in care 3
• Estrogen-containing contraceptives should be avoided due to increased thrombotic risk in this already hypercoagulable population
• Progestin-only methods are preferred: IUDs (7% current use), Depo-Provera (8% current use), or progestin-only pills 3
• Barrier methods alone (12% current use) have high failure rates and are insufficient as sole contraception 3
• Permanent sterilization (12% current use) should be discussed if family planning is complete 3

Specific Contraceptive Algorithm:

1. First-line: Levonorgestrel IUD (52mg) - highly effective, no estrogen, minimal systemic absorption
2. Second-line: Etonogestrel implant or Depo-Provera injections
3. Avoid: Combined oral contraceptives, vaginal rings, or patches containing estrogen
4. Backup: Barrier methods as adjunct only, never as sole method
5. Consider: Permanent sterilization if childbearing complete

Critical Pitfalls to Avoid

• Do not assume pregnancy is contraindicated - while high-risk, 46.7% live birth rate is achievable with proper monitoring 1
• Do not use estrogen-containing contraceptives - thrombotic risk is already elevated in Fontan physiology
• Do not rely on patient-reported "doing well" - 44% use no contraception, suggesting inadequate counseling 3
• Do not delay preconception evaluation if pregnancy desired - requires comprehensive cardiac assessment including right heart catheterization, cardiac MRI, stress testing, and pregnancy heart team assembly 7

Preconception Requirements if Pregnancy Desired

Should this patient desire pregnancy, she requires:

• Comprehensive cardiac evaluation: Right heart catheterization, cardiac MRI, stress echocardiography, ambulatory monitoring 7
• Risk stratification: Assess for ventricular dysfunction, significant atrioventricular valve regurgitation, arrhythmias, protein-losing enteropathy, or Fontan pathway obstruction 4
• Pregnancy heart team: Maternal-fetal medicine, cardiology, cardiac anesthesia, hematology 7, 8
• Thromboprophylaxis planning: Aspirin or enoxaparin protocols during pregnancy 1, 7
• Delivery planning: 85.7% require cesarean delivery, typically at tertiary centers 1

The key message: Effective contraception is mandatory given the 50% miscarriage rate and substantial maternal-fetal risks, but pregnancy is not absolutely contraindicated if the patient is carefully selected and monitored by a specialized pregnancy heart team.